Harbour BioMed and Glenmark Pharmaceuticals Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers Aug 7, 2018 Life Science
Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone Aug 7, 2018 Life Science
Naturally Splendid’s President and Co-Founder Presents Investor Roadshow at Cannabis Online Investment Conference Aug 2, 2018 Life Science
Clover Biopharmaceuticals Initiates Phase I Study of Etanercept Biosimilar Candidate SCB-808 in China Aug 1, 2018 Life Science
HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with Takeda Jul 31, 2018 Life Science
